Matthew Wineinger Net Worth

The estimated Net Worth of Matthew David Wineinger is at least $1.41 Million dollars as of 4 March 2024. Mr. Wineinger owns over 1,333 units of Balchem stock worth over $1,010,383 and over the last 9 years he sold BCPC stock worth over $209,134. In addition, he makes $194,836 as Independent Director at Balchem.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Wineinger BCPC stock SEC Form 4 insiders trading

Matthew has made over 1 trades of the Balchem stock since 2024, according to the Form 4 filled with the SEC. Most recently he sold 1,333 units of BCPC stock worth $209,134 on 4 March 2024.

The largest trade he's ever made was selling 1,333 units of Balchem stock on 4 March 2024 worth over $209,134. On average, Matthew trades about 133 units every 0 days since 2016. As of 4 March 2024 he still owns at least 6,162 units of Balchem stock.

You can see the complete history of Mr. Wineinger stock trades at the bottom of the page.

Matthew Wineinger biography

Matthew D. Wineinger serves as Independent Director of the Company. Since June 2015, Mr. Wineinger has been the President and Chief Executive Officer of United Sugars Corporation, a privately held, leading marketer of sugar. Mr. Wineinger served as President of Bulk Ingredients from June 2010 to November 2014. President, Food and Industrial Ingredients of Tate & Lyle PLC (LSE) from March 2008 to June 2010.

What is the salary of Matthew Wineinger?

As the Independent Director of Balchem, the total compensation of Matthew Wineinger at Balchem is $194,836. There are 11 executives at Balchem getting paid more, with Theodore Harris having the highest compensation of $3,808,410.

How old is Matthew Wineinger?

Matthew Wineinger is 53, he's been the Independent Director of Balchem since 2015. There are 9 older and 2 younger executives at Balchem. The oldest executive at Balchem Corp. is Perry Premdas, 67, who is the Independent Director.

What's Matthew Wineinger's mailing address?

Matthew's mailing address filed with the SEC is C/O BALCHEM CORPORATION, 5 PARAGON DRIVE, MONTVALE, NJ, 07645.

Insiders trading at Balchem

Over the last 21 years, insiders at Balchem have traded over $37,143,279 worth of Balchem stock and bought 47,350 units worth $1,702,145 . The most active insiders traders include Dino A Rossi, Frank Fitzpatrick, and David F Ludwig. On average, Balchem executives and independent directors trade stock every 36 days with the average trade being worth of $2,396,094. The most recent stock trade was executed by Gunsteren Job Leonard Van on 31 July 2024, trading 7,750 units of BCPC stock currently worth $462,288.

What does Balchem do?

founded in 1967, balchem provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. our company consists of four business segments: human nutrition & health; specialty products; animal nutrition and health and industrial products. balchem employs approximately 1,000 people worldwide who are engaged in many diverse activities, developing our company into chosen market leadership positions. visit our website at www.balchem.com to learn more about us and the exciting opportunities we have available!

Complete history of Mr. Wineinger stock trades at Balchem

Balchem executives and stock owners

Balchem executives and other stock owners filed with the SEC include:

• Theodore Harris,
  Chairman of the Board, President, Chief Executive Officer
• Theodore L. Harris,
  Chairman, CEO & Pres
• Martin Bengtsson,
  Chief Financial Officer
• Scott Mason,
  Vice President of Manufacturing and Supply Chain and Vice President and General Manager, Industrial Products
• William Backus,
  Chief Accounting Officer
• Mark Stach,
  General Counsel, Secretary
• Carl Martin Bengtsson,
  CFO & Treasurer
• James C. Hyde,
  Sr. VP and GM of Human Nutrition & Health
• Mark A. Stach,
  Gen. Counsel & Corp. Sec.
• John Televantos,
  Lead Independent Director
• Daniel Knutson,
  Independent Director
• Matthew Wineinger,
  Independent Director
• Perry Premdas,
  Independent Director
• David Fischer,
  Independent Director
• Paul Coombs,
  Independent Director
• Joyce Lee,
  Independent Director
• Dino A Rossi,
  President and CEO
• Edward Mcmillan,
  Director
• Matthew David Houston,
  General Counsel, Secretary
• Frank Fitzpatrick,
  Corp Controller & Treasurer
• Mary Theresa Coelho,
  Chief Financial Officer
• Monica Vicente,
  
• Olivier Rigaud,
  
• Elaine R Wedral,
  Director
• Richard Allen Bendure,
  Chief Operating Officer
• Francis X Mcdermott,
  Director
• Paul H Richardson,
  VP Research and Development
• Dana E. Putnam,
  VP and General Manager
• Cruce Patricia Siuta,
  Vice President Technology
• Israel Sheinberg,
  Director
• Winston A Samuels,
  Vice President/GM Encapsulates
• Hoyt Jr Ammidon,
  Director
• Kenneth P Mitchell,
  Director
• Robert T Miniger,
  VP/Human Resources
• David F Ludwig,
  Vice President
• James C Hyde,
  Sr. Vice President
• Kathleen B Fish,
  
• Frederic Boned,
  SVP/GM, Human Nutri. & Health
• Martin Luther Reid,
  SVP Chief Supply Chain Officer
• Hatsuki Miyata,
  EVP, Gen. Counsel & Secretary
• Gunsteren Job Leonard Van,
  SVP and GM, Specialty Products
• Michael Robert Sestrick,
  SVP & Chief Technology Officer
• Michael Brent Tignor,
  SVP & Chief HR Officer
• Jonathan Harrison Griffin,
  SVP & GM, Animal Nutrition